Literature DB >> 21577201

Association and dissociation of autophagy, apoptosis and necrosis by systematic chemical study.

S Shen1, O Kepp, M Michaud, I Martins, H Minoux, D Métivier, M C Maiuri, R T Kroemer, G Kroemer.   

Abstract

To address the question of whether established or experimental anticancer chemotherapeutics can exert their cytotoxic effects by autophagy, we performed a high-content screen on a set of cytotoxic agents. We simultaneously determined parameters of autophagy, apoptosis and necrosis on cells exposed to -1400 compounds. Many agents induced a 'pure' autophagic, apoptotic or necrotic phenotype, whereas less than 100 simultaneously induced autophagy, apoptosis and necrosis. A systematic analysis of the autophagic flux induced by the most potent 80 inducers of GFP-LC3 puncta among the NCI panel agents showed that 59 among them truly induced autophagy. The remaining 21 compounds were potent inducers of apoptosis or necrosis, yet failed to stimulate an autophagic flux, which were characterized as microtubule inhibitors. Knockdown of ATG7 was efficient in preventing GFP-LC3 puncta, yet failed to attenuate cell death by the agents that induce GFP-LC3 puncta. Thus there is not a single compound that would induce cell death by autophagy in our screening, underscoring the idea that cell death is rarely, if ever, executed by autophagy in human cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21577201     DOI: 10.1038/onc.2011.168

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  64 in total

Review 1.  Cell death by autophagy: facts and apparent artefacts.

Authors:  D Denton; S Nicolson; S Kumar
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

2.  Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens.

Authors:  Sylvain Ladoire; Kariman Chaba; Isabelle Martins; Abdul Qader Sukkurwala; Sandy Adjemian; Mickaël Michaud; Vichnou Poirier-Colame; Felipe Andreiuolo; Lorenzo Galluzzi; Eileen White; Mathias Rosenfeldt; Kevin M Ryan; Laurence Zitvogel; Guido Kroemer
Journal:  Autophagy       Date:  2012-05-31       Impact factor: 16.016

Review 3.  Autophagy inhibitors.

Authors:  Benoit Pasquier
Journal:  Cell Mol Life Sci       Date:  2015-12-11       Impact factor: 9.261

Review 4.  Regulation of lipid stores and metabolism by lipophagy.

Authors:  K Liu; M J Czaja
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

5.  Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia.

Authors:  Yang Liu; Sanae Shoji-Kawata; Rhea M Sumpter; Yongjie Wei; Vanessa Ginet; Liying Zhang; Bruce Posner; Khoa A Tran; Douglas R Green; Ramnik J Xavier; Stanley Y Shaw; Peter G H Clarke; Julien Puyal; Beth Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

Review 6.  Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.

Authors:  S Fulda; D Kögel
Journal:  Oncogene       Date:  2015-01-26       Impact factor: 9.867

Review 7.  Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate.

Authors:  Robert Clarke; Katherine L Cook; Rong Hu; Caroline O B Facey; Iman Tavassoly; Jessica L Schwartz; William T Baumann; John J Tyson; Jianhua Xuan; Yue Wang; Anni Wärri; Ayesha N Shajahan
Journal:  Cancer Res       Date:  2012-03-15       Impact factor: 12.701

8.  Autophagy and senescence: a partnership in search of definition.

Authors:  David A Gewirtz
Journal:  Autophagy       Date:  2013-02-19       Impact factor: 16.016

9.  Combination of Cl‑IB‑MECA with paclitaxel is a highly effective cytotoxic therapy causing mTOR‑dependent autophagy and mitotic catastrophe on human melanoma cells.

Authors:  Ana S Soares; Vera M Costa; Carmen Diniz; Paula Fresco
Journal:  J Cancer Res Clin Oncol       Date:  2014-06       Impact factor: 4.553

Review 10.  Autophagy and cancer therapy.

Authors:  Andrew Thorburn; Douglas H Thamm; Daniel L Gustafson
Journal:  Mol Pharmacol       Date:  2014-02-26       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.